EP300 and breast cancer: Mechanistically, activation of AR in ER+ breast cancer cells sequestered essential transcriptional co-activators (p300, SRC-3) away from ER-regulated cell cycle genes to up-regulate AR target genes, including known tumor suppressors [8].